Fulvestrant for the treatment of advanced breast cancer

QR Code

Fulvestrant for the treatment of advanced breast cancer

Introduction: The current issues with endocrine therapy for treatment of advanced breast cancer include balance of efficacy of therapy versus tolerability as well as hormone resistance. The efficacy of fulvestrant, a selective oestrogen receptor degrader (SERD), has been demonstrated in hormone rece...

Full description

Bibliographic Details
Main Authors:	Blackburn, Sophie A., Parks, Ruth M., Cheung, Kwok-Leung
Format:	Article
Published:	Taylor & Francis 2018
Online Access:	https://eprints.nottingham.ac.uk/52665/

Similar Items

Health-related quality of life from the FALCON phase III randomised trial of fulvestrant 500 mg versus anastrozole for hormone receptor-positive advanced breast cancer
by: Robertson, John F.R., et al.
Published: (2018)

Baseline quality of life evaluation in older women with primary operable breast cancer and its relationship with different treatments
by: Zahit, Ross A., et al.
Published: (2018)

Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial
by: Robertson, John F.R., et al.
Published: (2017)

Optimising endocrine therapy in postmenopausal women with advanced breast cancer
by: Yau, Thomas Ho Lai, et al.
Published: (2018)

Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase 11 study
by: Hyams, D., et al.
Published: (2013)

Biological assessment - developing a novel tool to guide treatment decision in older women with primary breast cancer
by: Parks, Ruth M.
Published: (2023)

A continuing mission to optimize the care of older women with breast cancer
by: Cheung, Kwok-Leung
Published: (2017)

Endocrine therapy for breast cancer: a model of hormonal manipulation
by: Johnston, Simon J., et al.
Published: (2018)

Axillary reverse mapping in N0 patients requiring sentinel lymph node biopsy: a systematic review of the literature and necessity of a randomised study
by: Parks, R.M., et al.
Published: (2017)

The development of novel theranostic agents for breast cancer imaging and treatment
by: Duthoit, Sophie
Published: (2021)

Recent advances in nanotheranostics for triple negative breast cancer treatment
by: Thakur, Vikram, et al.
Published: (2019)

What influences healthcare professionals' treatment preferences for older women with operable breast cancer?: an application of the discrete choice experiment
by: Morgan, J.L., et al.
Published: (2017)

4th symposium on primary breast cancer in older women. Theme: putting personalized care into practice (held: 3 March 2017)
by: Cheung, Kwok-Leung, et al.
Published: (2017)

Controversial issues in the management of older adults with early breast cancer
by: Mislang, Anna Rachelle, et al.
Published: (2017)

Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer
by: Alexander, Angela, et al.
Published: (2017)

Treatment strategies and survival outcomes in older women with breast cancer: a comparative study between the FOCUS cohort and Nottingham cohort
by: Schuil, Hugo, et al.
Published: (2018)

Polyadenylation as a target for the treatment of breast cancer
by: Thiyab, Asraa
Published: (2025)

Understanding factors associated with delay in seeking treatment among locally advanced and metastatic breast cancer in Hospital Raja Perempuan Zainab II
by: Karim, Mohd Firdaus A.
Published: (2020)

Cytoplasmic cyclin E predicts recurrence in patients with breast cancer
by: Hunt, Kelly K., et al.
Published: (2016)

Potential role of targeted therapies in the treatment of triple-negative breast cancer
by: Jia, L., et al.
Published: (2016)

Recent advances in the development of multifunctional lipid-based nanoparticles for co-delivery, combination treatment strategies, and theranostics in breast and lung cancer
by: Loo, Yan Shan, et al.
Published: (2022)

Correlates of resistance training in post-treatment breast cancer survivors
by: Short, C., et al.
Published: (2014)

The role of the breast care nurse during treatment for early breast cancer: the patient's perspective.
by: Halkett, Georgia
Published: (2006)

Preoperative taxane-based chemotherapy in a standardized protocol for locally advanced breast cancer
by: Chan, Arlene, et al.
Published: (2012)

Oestrogen receptor negative early operable primary breast cancer in older women—biological characteristics and long-term clinical outcome
by: Coleman, William B., et al.
Published: (2017)

Nanomedicine using Quercus infectoria Extract for the treatment of Breast Cancer
by: Wan Nur, Suzilla, et al.
Published: (2020)

Decision making in breast cancer treatment: a qualitative inquiry
by: Mohd Shariff, Zalilah, et al.
Published: (2008)

Delay in seeking diagnosis and treatment among women with breast cancer
by: Norsa'adah, Bachok
Published: (2012)

The breast cancer patient's experience of making radiation therapy treatment decisions
by: Halkett, Georgia, et al.
Published: (2005)

Identification of oestrone sulphatase inhibitors in breast cyst fluid: a new treatment for breast cancer
by: Lai, L. C.
Published: (1999)

First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study
by: Bergh, J., et al.
Published: (2012)

Patterns of surgical treatment for women diagnosed with early breast cancer in Queensland
by: Thompson, B., et al.
Published: (2008)

Thiazolidinediones Pretreated Bone Marrow-Derived Mesenchymal Stem Cells As An Anti-Cancer Approach Against Mcf-7 Breast Cancer Cell Line
by: Lim, Shern Kwok
Published: (2022)

Religion and spirituality in coping with advanced breast cancer: perspectives from Malaysian Muslim women
by: Ahmad, Farizah, et al.
Published: (2011)

Low level of BRCA-1 mutations in Malaysian breast cancer patients
by: f, Salih, et al.
Published: (2010)

The role of self-help group in Jordan following treatment for breast cancer
by: Mahasneh, Deema
Published: (2015)

Role of calpain in breast cancer and regulation of therapeutic response to targeted treatment
by: Pu, Xuan
Published: (2016)

Engineering apoferritin for targeted delivery of peptides or proteins for the treatment of breast cancer
by: Ferreira, Lenny
Published: (2023)

Development and Encapsulation of Affibody-Apoferritin Biologics for the Targeted Treatment of Breast Cancer
by: Holden, Isobel R
Published: (2025)

Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer
by: Chan, Arlene, et al.
Published: (2010)